Global and United States Irritable Bowel Syndrome (IBS) Market Research by Company, Type & Application 2013-2025
Summary
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Market Segment as follows:
By Type
Section 1: Product definition, type and application, global and United States market overview;
Section 2: Global and United States Market competition by company;
Section 3: Global and United States sales revenue, volume and price by type;
Section 4: Global and United States sales revenue, volume and price by application;
Section 5: United States export and import;
Section 6: Company information, business overview, sales data and product specifications;
Section 7: Industry chain and raw materials;
Section 8: SWOT and Porter's Five Forces;
Section 9: Conclusion.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Market Segment as follows:
By Type
- IBS-D Drug
- IBS-C Drug
- Others
- Women
- Men
- Valeant Pharmaceuticals
- Allergan
- Takeda
- Sucampo Pharmaceuticals
- McNeil Consumer Healthcare
- Sebela Pharmaceuticals
- Astellas Pharmaceuticals
- IM HealthScience
Section 1: Product definition, type and application, global and United States market overview;
Section 2: Global and United States Market competition by company;
Section 3: Global and United States sales revenue, volume and price by type;
Section 4: Global and United States sales revenue, volume and price by application;
Section 5: United States export and import;
Section 6: Company information, business overview, sales data and product specifications;
Section 7: Industry chain and raw materials;
Section 8: SWOT and Porter's Five Forces;
Section 9: Conclusion.
1 MARKET OVERVIEW
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 IBS-D Drug
1.1.2.2 IBS-C Drug
1.1.2.3 Others
1.1.3 Market by Application
1.1.3.1 Women
1.1.3.2 Men
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Valeant Pharmaceuticals
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Allergan
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Takeda
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Sucampo Pharmaceuticals
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 McNeil Consumer Healthcare
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Sebela Pharmaceuticals
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Astellas Pharmaceuticals
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 IM HealthScience
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 IBS-D Drug
1.1.2.2 IBS-C Drug
1.1.2.3 Others
1.1.3 Market by Application
1.1.3.1 Women
1.1.3.2 Men
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Valeant Pharmaceuticals
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Allergan
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Takeda
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Sucampo Pharmaceuticals
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 McNeil Consumer Healthcare
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Sebela Pharmaceuticals
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Astellas Pharmaceuticals
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 IM HealthScience
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
LIST OF TABLES
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Valeant Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Allergan
Table Sales Revenue, Volume, Price, Cost and Margin of Takeda
Table Sales Revenue, Volume, Price, Cost and Margin of Sucampo Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of McNeil Consumer Healthcare
Table Sales Revenue, Volume, Price, Cost and Margin of Sebela Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of IM HealthScience
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Valeant Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Allergan
Table Sales Revenue, Volume, Price, Cost and Margin of Takeda
Table Sales Revenue, Volume, Price, Cost and Margin of Sucampo Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of McNeil Consumer Healthcare
Table Sales Revenue, Volume, Price, Cost and Margin of Sebela Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of IM HealthScience
LIST OF FIGURES
Figure IBS-D Drug Market Size and CAGR 2013-2017 (Million USD)
Figure IBS-D Drug Market Size and CAGR 2013-2017 (Volume)
Figure IBS-D Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure IBS-D Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure IBS-C Drug Market Size and CAGR 2013-2017 (Million USD)
Figure IBS-C Drug Market Size and CAGR 2013-2017 (Volume)
Figure IBS-C Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure IBS-C Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Women Market Size and CAGR 2013-2017 (Million USD)
Figure Women Market Size and CAGR 2013-2017 (Volume)
Figure Women Market Forecast and CAGR 2018-2025 (Million USD)
Figure Women Market Forecast and CAGR 2018-2025 (Volume)
Figure Men Market Size and CAGR 2013-2017 (Million USD)
Figure Men Market Size and CAGR 2013-2017 (Volume)
Figure Men Market Forecast and CAGR 2018-2025 (Million USD)
Figure Men Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Million USD)
Figure Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Volume)
Figure Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Million USD)
Figure United States Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Volume)
Figure United States Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Irritable Bowel Syndrome (IBS) SWOT List
Figure Healthcare & Medical Porter's Five Forces
Figure IBS-D Drug Market Size and CAGR 2013-2017 (Million USD)
Figure IBS-D Drug Market Size and CAGR 2013-2017 (Volume)
Figure IBS-D Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure IBS-D Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure IBS-C Drug Market Size and CAGR 2013-2017 (Million USD)
Figure IBS-C Drug Market Size and CAGR 2013-2017 (Volume)
Figure IBS-C Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure IBS-C Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Women Market Size and CAGR 2013-2017 (Million USD)
Figure Women Market Size and CAGR 2013-2017 (Volume)
Figure Women Market Forecast and CAGR 2018-2025 (Million USD)
Figure Women Market Forecast and CAGR 2018-2025 (Volume)
Figure Men Market Size and CAGR 2013-2017 (Million USD)
Figure Men Market Size and CAGR 2013-2017 (Volume)
Figure Men Market Forecast and CAGR 2018-2025 (Million USD)
Figure Men Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Million USD)
Figure Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Volume)
Figure Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Million USD)
Figure United States Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Volume)
Figure United States Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Irritable Bowel Syndrome (IBS) SWOT List
Figure Healthcare & Medical Porter's Five Forces
